The role of perinatal perceived stress in the setting of adverse childhood experience and perinatal anxiety and depressive symptoms Authors: Folasade Ilori, Nickie N Andescavage, Katherine L Wisner, Julius S Ngwa, Rathinaswamy B Govindan, Catherine Limperopoulos Published: 2025 ABSTRACT AbstractBackgroundAdverse childhood experiences (ACE) are highly prevalent, with long-lasting effects on physical and mental health that vary among individuals across their lifespan. Notably, ACE is associated with depression and anxiety disorders, which are major public health concerns. However, the factors involved in the detrimental effects of ACE on women in the perinatal period, a time of heightened vulnerability to physical and mental health outcomes for both mothers and their offspring, require further investigation.MethodsTo investigate the role of perceived stress in the association between ACE and maternal depressive and anxiety symptoms across the perinatal period, we included 138 pregnant women recruited for a prospective longitudinal study that examined the effects of increased maternal prenatal stress on pregnancy during the COVID-19 pandemic. Participants self-reported adverse childhood experiences and serial measures of perceived stress, anxiety, and depressive symptoms. Linear mixed-effects (LME) models were employed to assess the association between ACE, perceived stress, anxiety, and depressive symptoms and to determine an interaction effect between ACE and perceived stress on state anxiety, trait anxiety, and depressive symptoms.ResultsOn average, participants were 34 years of age and at 26 weeks of gestation (gestational age; GA). We found a significant interaction between ACE and perceived stress on trait anxiety (β = 0.06, SE = 0.01, p < .001) and depressive symptoms (β = 0.07, SE = 0.01, p < .001) in the perinatal period. Perceived stress moderated the association between ACE and trait anxiety symptoms in the third trimester (β = 0.07, SE = 0.02, p < .001). The association between ACE and depressive symptoms was moderated by perceived stress in the first trimester (β = 0.23, SE = 0.09, p < .05), second trimester (β = 0.09, SE = 0.03, p < .05), and third trimester (β = 0.04, SE = 0.02, p < .05).ConclusionThese findings underscore the importance of assessing ACE as a risk factor when evaluating maternal mental health to identify individuals susceptible to depressive and anxiety disorders in the perinatal period. Moreover, multiple mental health screenings in the perinatal period reduce the risk of missed opportunities for intervention and preventative actions.Supplementary InformationThe online version contains supplementary material available at 10.1186/s40359-025-03628-6.Keywords: Adverse childhood experience, Perinatal period, Mental health Introduction Stress is well established as a key contributor to neuropsychiatric disorders, with differential effects on individuals depending on the developmental stage at which it is experienced [1]. The effects of stress on women are particularly pronounced during periods of hormonal fluctuation, such as puberty, pregnancy, and perimenopause [2, 3]. Notably, the perinatal period represents a vulnerable time for maternal mood disorders, adverse physical health outcomes, and changes in offspring development [4–7]. This time is crucial because the fetus is also vulnerable to altered neurodevelopmental trajectories and changes in neuro-circuitry associated with emotion regulation [8, 9]. Prenatal exposure to maternal psychological and physiological changes is further known to increase the risk of mood and anxiety disorders in offspring [10–12]. Perinatal mood and anxiety disorders (PMADs), which encompass depression and anxiety disorders, affect approximately 15% to 22% of women during pregnancy and the postpartum period and are the most prevalent complication associated with pregnancy [13–16]. However, considerable heterogeneity exists in the etiology, symptoms, and treatment responses for PMADs, leaving many questions unanswered. Notably, the impact of stress experiences during a formative period of development, such as childhood, on psychological, behavioral, and neurological developmental trajectories for pregnant and post-partum women is not well-explored. Adverse childhood experiences (ACE), also known as early life stress or early life adversities, are potentially traumatic or stressful events that occur in childhood (ages 0 −17) with lifelong implications. Approximately 64% of adults report ACE, and about 17% —predominately women—report experiencing four or more types of ACE [17, 18]. And yet, individuals who report at least one form of childhood adversity are at greater risk for neuropsychiatric disorders due to altered emotion regulation and stress reactivity across the lifespan [19–21]. Despite the prevalence of ACE and evidence of its association with mental disorders across the lifespan, the underlying mechanisms involved in this association are not fully understood due to individual differences in stress appraisal, perception, coping, and physical and mental health outcomes. The stress sensitization model offers a valuable theoretical framework to understand how early life adversity increases the risk of mental health disorders. The model posits that early life stress heightens an individual’s sensitivity to subsequent proximal stressors, thus amplifying susceptibility to psychopathology [22]. This may occur through the development of maladaptive stress appraisal patterns or heightened emotional reactivity, which makes later stressors more psychologically disruptive [23]. ACEs are also thought to become biologically embedded by dysregulating and altering the development of the central stress response system, the hypothalamic–pituitary–adrenal axis (HPA axis), leading to heightened or dampened biological and psychological reactivity to stress in adulthood [24]. Therefore, while ACE is conceptually distinct from current stress severity, it may contribute to enduring changes in how individuals perceive and respond to stress, increasing emotional reactivity and sensitivity to stress [25] particularly during high-demand periods such as the perinatal period, a time of substantial physiological and psychological transition [26]. In this work, we further sought to explore the relationship between ACE, which may heighten sensitivity to stress, and the subjective experience of perceived stress [25] across the perinatal period. High perceived stress in the perinatal period has been consistently linked to poorer maternal mental health outcomes, including elevated symptoms of anxiety and depression, underscoring its clinical relevance [27–29]. More specifically, we further evaluate these relationships relative to trait anxiety, a relatively stable disposition to hypervigilance or worry [30–32] characterized by autonomic and central nervous system dysregulations [33, 34], as well as state anxiety that reflects transient emotional states triggered by specific circumstances or situational stressors [33] such as the COVID-19 pandemic. Both forms are relevant in the perinatal context, as this period is inherently stressful [35] More importantly, perceived stress can further exacerbate anxiety symptoms in those with heightened dispositional sensitivity to stress and subsequently contribute to an elevated psychological risk [36, 37]. Therefore, we aim to examine the role of perceived stress in the association between ACE and maternal depressive and anxiety symptoms across the perinatal period. Methods and materials Participants Women were recruited in a prospective longitudinal study assessing the effects of maternal prenatal stress on pregnancy and early childhood neurodevelopment from June 2020 through 2023, including serial assessments of maternal mental health, fetal-neonatal magnetic resonance imaging and offspring developmental assessments. Participants were recruited through various communication methods, including parenting websites, social media posts from Children’s National Public Relations/Marketing, maternal listservs, and regional obstetric sites. Eligibility criteria included: 1) 18 years of age or more with a single-ton pregnancy of at least eight weeks; 2) no health risk factors other than being pregnant during the COVID-19 pandemic; 3) having a diagnosis or exhibiting symptoms of stress, anxiety, or depression based on participant self-report. Exclusion criteria included: 1) pregnant with a fetus with known chromosomal syndromic conditions, or 2) high-risk pregnancy, such as diabetes, hypertension, or placental disorders. A study staff member reviewed the consent with eligible participants to review the purpose of the study and study procedures. Each participant had an opportunity to independently review the consent form, ask questions, and determine their decision to participate. Compensation was provided to participants for each fetal MRI visit, developmental visit, and neonatal MRI visit, as well as additional compensation for completion of all prenatal questionnaires. All participants signed a consent form prior to the initiation of study-specific procedures. This report includes data collected from maternal mental health questionnaires. Measures All participants completed a standardized self-report measure of adverse childhood experiences, perceived stress, anxiety, and depressive symptoms every two weeks, beginning two weeks after their enrollment. These measures are validated for use in adults and pregnant women. While schedules varied based on time of enrollment, participants received a secure link at two-week intervals from the time of their enrollment to complete the questionnaires on their personal devices via email or text prompt. Maternal exposure to childhood adversity was assessed at enrollment with the Adverse Childhood Experience (ACE) scale, a measure of exposure to stressful or traumatic events during childhood (0–17 years), such as neglect, abuse, or household dysfunction [38]. ACE scores range from 0 to 10, with 0 indicating no adverse experiences and higher scores indicating more exposure to adversity [38]. An ACE score between 1 and 3 indicates moderate ACE exposure, while 4 or higher indicates high ACE exposure [38]. Cronbach’s alpha coefficient has been reported as 0.76, and a study in pregnant women reported a Cronbach’s alpha coefficient ranging from 0.71 to 0.92 [39]. Maternal perceived stress and mental health symptoms were assessed every two weeks from the time of enrollment in the study. Maternal stress was assessed with the Perceived Stress Scale (PSS), a 10-item scale that measures the extent to which an individual perceives current situations in their life as stressful. Scores range from 0 to 40, and higher scores indicate increased stress perception [40]. Perceived stress scores range from 0 to 13 (low), 14 to 26 (moderate), and 27 to 40 (high) [40]. The Cronbach alpha coefficient for the 10-item PSS has been consistently reported as greater than 0.70 across multiple studies, with reports of 0.84 for women specifically [41] The State-Trait Anxiety Inventory (STAI) was used to measure maternal anxiety levels. STAI is a 40-item test that measures both current anxiety levels (state anxiety) and dispositional levels of anxiety (trait anxiety), with individual scores for each. A higher score indicates greater levels of anxiety symptoms. Scores range from 20 to 80, whereby scores of 20 to 37 indicate low anxiety symptoms, 38 to 44 (moderate), and 45 to 80 (high) [42]. Cronbach’s alpha coefficient has been reported as 0.93 for trait and 0.95 for state in non-pregnant individuals, and while scores are known to fluctuate during pregnancy, it is one of the most widely used constructs to study anxiety in pregnancy [43–45]. The Center for Epidemiological Studies-Depression (CES-D) is a 20-item scale used to characterize depressive symptoms. Scores range from 0 to 60; a score of 16 and above indicates a risk of major depressive disorder [46]. The CES-D has demonstrated strong internal consistency, with a Cronbach’s alpha coefficient ranging from 0.84 to 0.90 [46]. Cronbach’s alpha coefficient, ranging from 0.88 to 0.93, has also been reported in pregnant women [47]. Procedures Our sample included 138 pregnant women (N = 138) with a mean (standard deviation) age of 34 (4.67) years who completed the ACE questionnaire and maternal mental health measures (Fig. 1, Table 1). Participants were enrolled in the study at a mean (standard deviation) gestational age of 25.86 (10.94) weeks. Of these, 43% (n = 63) reported no ACEs, 40% (n = 55) reported at least one ACE, and 14% (n = 20) of the women reported exposure to 4 or more ACEs (Fig. 1). Total count of repeated measures assessment (n = 1535) and the counts at each time point across are also illustrated in Fig. 1. Flowchart of participant enrollment, ACE scores, and repeated assessments. Note. N = 138 represents the number of unique participants. Adverse Childhood Experience (ACE) branches reflect the number of participants who completed the ACE measure by score range. Lowercase n indicates the number of assessments. The total number of repeated assessments (STAI = State-Trait Anxiety Inventory; CES-D = Center for Epidemiological Studies-Depression; and PSS = Perceived Stress Scale) is shown, followed by the number of assessments by trimester and postnatal period Table 1Demographics of study participantsMean (SD); N (%)Age (years)33.80 (4.67)Gestational Age (GA) at Enrollment (weeks)25.86 (10.94)Gravida (count) 149 (36) 237 (27) 321 (15) ≥ 415 (11) Unknown16 (12)Race Asian or Pacific Islander15 (11) Black21 (15) Hispanic18 (13) White80 (58) Other2 (1)Education < 7th Grade2 (1) High School Graduate5 (4) Partial College8 (6) University Graduate33 (24) Graduate Degree74 (54) Unknown16 (12) Demographics of study participants Data analysis All data processing and statistical analyses were performed using R Studio version 4.4.1 [48]. Descriptive statistics were computed for maternal age, gestational age (GA) at enrollment, gravida, race, education, ACE, perceived stress, and depressive and anxiety symptoms. Mean and standard deviations were computed for maternal age and gestational age, while count and percentage were computed for gravida, race, and education. The predictors in the analysis were total scores of ACE and PSS. The outcome variables were the total score of state anxiety, trait anxiety, and depressive symptoms measured across the perinatal period. The total scores for all variables provide the level and severity of the constructs being measured in each participant. A linear mixed-effects (LME) model was used to evaluate the association between ACE, perceived stress, anxiety, and depressive symptoms, as well as the effect of an interaction between ACE and perceived stress on state anxiety, trait anxiety, and depressive symptoms. In the LME model, participants were clustered by participants using a random intercept approach based on repeated measures of PSS, STAI, and CES-D. In addition, based on varying GA at the time of repeated measures assessment, a random slope approach was also incorporated to account for varying GA. Each outcome of interest was analyzed in separate models. Additional subgroup analyses were conducted to examine whether the results of the primary analysis vary across time, namely in the prenatal (first, second, and third trimesters) and the postnatal period (first year following childbirth). The random intercept model was clustered by participants and examined by trimester. Additional models included maternal age, race/ethnicity, and education as covariates, as well as gestational age at birth for postnatal period analyses. None of these covariates were significantly associated with the outcomes of interest, nor did they alter the main or interaction effects. Given their minimal contribution to model performance and interpretation, they were not retained in the final models. Missing data was handled using linear mixed effects modeling with restricted maximum likelihood estimation (REML), which includes all available data without listwise deletion. This method assumes data is missing at random, providing unbiased estimates. Participants were included if they had complete data for ACE exposure, perceived stress, and outcome measures. A comparison of demographic characteristics between those with complete and missing ACE data was conducted to assess potential bias. Results The total number of assessments was limited in the first trimester across all self-report measures of the study (n = 18) because most women were enrolled during their second trimester. Participants were assessed every two weeks across the perinatal period, but the total number of time points varied by participant depending on their timing of enrollment. Of those 138 included in the study, only 7 participants (5%) completed surveys at a single time point. As illustrated in Fig. 1, the number of repeated measures per participant varied based on gestational age at enrollment, with the majority (80%) completing the 3rd trimester and postnatal data. Of those who completed 3rd trimester and postnatal data, 48 (76%) reported low ACE, 46(84%) reported moderate ACE, and 17(85%) reported high ACE (See supplemental materials, Table S4). Table 1 summarizes the demographics of the participants in the study. Table 2 presents the descriptive statistics for state and trait anxiety, depressive symptoms, and perceived stress across levels of ACE for the prenatal (first, second, and third trimesters) and the postnatal period, with corresponding p-values to indicate whether significant differences exist across levels of ACE. In the unadjusted analyses to compute descriptive statistics, we found that depressive symptoms were significantly higher for those with high ACE compared to those with moderate and low ACE in the 1 st (p =.03) and 2nd trimester (p =.01). Similarly, perceived stress scores were significantly higher for those who reported high ACE compared to moderate and low ACE in the 2nd trimester (p =.02). Table 2Descriptives of anxiety, depressive symptoms, and perceived stress at different levelsACE Categories LS mean (SE)VariablesLowModerateHighp-value 1 st TrimesterSTAI-S30 (7.19)41.13 (3.97)47.5 (7.81)0.28STAI-T31.5 (5.19)36.02 (2.87)49 (5.65)0.11CESD11.25 (4.69)17.24 (2.60)34.5 (5.15)0.03PSS7.5 (3.06)15.50 (1.65)23 (3.14)0.022nd TrimesterSTAI-S34.21 (1.51)36.21 (1.44)39.74 (2.70)0.20STAI-T34.44 (1.45)35.87 (1.40)41.17 (2.47)0.07CESD12.50 (1.18)15.81 (1.11)19.99 (2.10)0.01PSS13.25 (1.03)15.24 (0.98)17.83 (1.77)0.073rd TrimesterSTAI-S33.64 (1.16)33.29 (1.22)33.01 (2.01)0.96STAI-T32.83 (1.15)34.83 (1.22)35.08 (1.99)0.41CESD12.69 (0.92)14.10 (0.96)16.85 (1.55)0.07PSS12.65 (0.80)14.68 (0.86)13.46 (1.39)0.23Postnatal PeriodSTAI-S33.28 (1.09)34.15 (1.11)29.42 (1.93)0.11STAI-T34.27 (1.13)35.66 (1.56)32.62 (1.97)0.38CESD12.34 (0.99)14.44 (0.97)13.09 (1.85)0.32PSS13.34 (0.81)14.77 (0.81)12.73 (1.39)0.31Least squares means and standard errors were estimated using a linear mixed effects model to account for within-subjects correlations across repeated measuresAbbreviations: ACE Adverse Childhood Experience, STAI-S state anxiety, STAI-T trait anxiety, CESD Center for Epidemiological Studies-Depression, PSS Perceived Stress Scale, LS mean least squares means, SE standard error of the mean, n sample size Descriptives of anxiety, depressive symptoms, and perceived stress at different levels Least squares means and standard errors were estimated using a linear mixed effects model to account for within-subjects correlations across repeated measures Abbreviations: ACE Adverse Childhood Experience, STAI-S state anxiety, STAI-T trait anxiety, CESD Center for Epidemiological Studies-Depression, PSS Perceived Stress Scale, LS mean least squares means, SE standard error of the mean, n sample size Main effect of ACE and PSS on maternal anxiety and depressive symptoms We begin by reporting the main effect of ACE on state anxiety, trait anxiety, and depressive symptoms across the perinatal period, which serves as a basis for subsequent interaction effects and temporal trend analyses. The LME model showed that ACE did not have a significant main effect on state anxiety, though perceived stress was significantly associated with state anxiety (β = 0.89, SE = 0.04, p = <.001), indicating that higher perceived stress scores were associated with higher state anxiety levels, independent of ACE (Table 3). Similarly, ACE did not have a significant main effect on trait anxiety (β = 0.22, SE = 0.24, p = 0.35). Perceived stress was also significantly associated with trait anxiety (β = 0.68, SE = 0.03, p <.001), whereby higher perceived stress scores were associated with higher state anxiety levels. We also found that ACE had a significant main effect on depressive symptoms (β = 0.54, SE = 0.18, p = 0.002). Perceived stress was also significantly associated with depressive symptoms (β = 0.68, SE = 0.03, p <.001), demonstrating that higher perceived stress scores were associated with higher depressive symptoms. Table 3Linear mixed effects model predicting state and trait anxiety and depressive symptomsMain effectInteraction EffectTermEstimateSEtdfp-valueR2cR2mEstimateSEtdfp-valueR2cR2mState Anxiety(Intercept)22.690.9025.25232.31<.0010.550.3523.131.0023.08286.29<.0010.550.34ACE−0.340.20−1.69123.600.09−0.600.34−1.77360.390.08PSS0.890.0422.70931.61<.0010.860.0517.24781.49<.001PSS GA−0.010.01−1.6755.950.10−0.010.01−1.7056.330.09ACE*PSS–-–-–-–-–-0.020.020.96694.540.34Trait Anxiety(Intercept)25.400.7832.72182.53<.0010.790.3226.740.8232.56230.07<.0010.790.32ACE0.220.240.93114.270.35−0.600.30−2.02254.820.04PSS0.680.0326.641404.17<.0010.580.0317.681387.74 <.001PSS GA−0.010.01−1.3350.630.19−0.010.01−1.3651.090.18ACE*PSS–-–-–-–-–-0.060.014.591263.93<.001Depressive Symptoms(Intercept)4.810.716.82181.55<.0010.660.416.400.768.38234.30<.0010.660.41ACE0.540.183.0598.930.002−0.420.27−1.58297.050.11PSS0.680.0322.75947.13<.0010.560.0414.79849.20<.001PSS GA−0.020.01−2.6640.380.01−0.020.01−2.7438.290.01ACE*PSS–-–-–-–-–-0.070.014.93637.62<.001Abbreviations: ACE Adverse Childhood Experience, PSS Perceived Stress Scale, GA Gestational age at the time of repeated measurement, SE standard error, t test statistic, df degrees of freedom, R2c conditional R-squared, R2m marginal R-squared Linear mixed effects model predicting state and trait anxiety and depressive symptoms Abbreviations: ACE Adverse Childhood Experience, PSS Perceived Stress Scale, GA Gestational age at the time of repeated measurement, SE standard error, t test statistic, df degrees of freedom, R2c conditional R-squared, R2m marginal R-squared Interaction effects of ACE and PSS on maternal anxiety and depressive symptoms We examined whether there is an interaction between ACE and perceived stress on anxiety and depressive symptoms, as shown in Table 3. There was no significant interaction effect of ACE and perceived stress on state anxiety (β = 0.02, SE = 0.02, p = 0.34). However, we did observe a significant interaction effect of ACE and perceived stress trait anxiety (β = 0.06, SE = 0.01, p <.001), suggesting that the association between ACE and trait anxiety is significant in the setting of increasing levels of perceived stress. There was also a significant interaction effect of ACE and perceived stress on depressive symptoms (β = 0.07, SE = 0.01, p <.001), indicating that the association between ACE and depressive symptoms is significant at increasing levels of perceived stress. Post-hoc simple slope analyses of the interaction between ACE and perceived A Johnson-Neyman analysis was conducted to examine how perceived stress moderates the relationship between ACE scores and maternal trait anxiety and depressive symptoms (Table 4). Table 4Johnson-Neyman analysisVariablePSS LevelEstimateS.Etp-valueTrait Anxiety−1 SD (7.04)−0.20.25−0.770.44Mean (13.53)0.180.240.750.45 + 1 SD (20.01)0.550.252.240.03Depressive Symptoms−1 SD (7.06)0.070.20.330.74Mean (13.54)0.510.182.930.00 + 1 SD (20.02)0.960.195.010.00Abbreviations: PSS Perceived Stress Scale, SD standard deviation, S.E. standard error of the mean, t statistic Johnson-Neyman analysis Abbreviations: PSS Perceived Stress Scale, SD standard deviation, S.E. standard error of the mean, t statistic For trait anxiety, Fig. 2 illustrates the Johnson-Neyman analysis result which indicated that ACE was significantly associated with higher trait anxiety only at high levels of perceived stress (+ 1 SD) (β = 0.55, p <.05). The slope was not significant at either the mean (β = 0.18, p = 0.45) or low levels of perceived stress (β = −0.20, p = 0.44). Interaction between Adverse Childhood Experiences (ACE) and Perceived Stress Scale (PSS) scores in predicting trait anxiety. Predicted trait anxiety values are plotted at + 1 SD, the mean, and −1 SD of PSS scores. Higher ACE scores were associated with greater trait anxiety, particularly at higher levels of perceived stress There was a significant interaction effect of ACE and perceived stress on depressive symptoms at both the mean (13.54) and + 1 SD (20.02) levels of perceived stress, as indicated by significant positive slopes (β = 0.51, p <.05 at mean; β = 0.96, p = <.05 at + 1 SD). Specifically, ACE was significantly associated with higher depressive symptoms when perceived stress was at or above average levels (Fig. 2). At lower levels of stress (− 1 SD), the relationship between ACEs and depressive symptoms was not significant (β = 0.07, p = 0.74) (Fig. 3). Interaction between Adverse Childhood Experiences (ACE) and Perceived Stress Scale (PSS) scores in predicting depressive symptoms. Predicted depressive symptoms values are plotted at + 1 SD, the mean, and −1 SD of PSS scores. Higher ACE scores were associated with greater depressive symptoms, particularly at higher levels of perceived stress Interaction effects of ACE and PSS on maternal anxiety and depressive symptoms across time A secondary analysis of the interaction between ACE and PSS on state anxiety, trait anxiety, and depressive symptoms across time in the prenatal and postnatal periods was conducted. Results are shown in Supplemental Table S1, Table S2, and Table S3, respectively. The subgroup analyses results showed that there was no significant interaction effect of ACE and PSS on state anxiety across time. However, we did observe a significant interaction effect of ACE and PSS on trait anxiety in the third trimester (β = 0.07, SE = 0.02, p <.001). Similarly, there was a significant interaction effect of ACE and PSS on depressive symptoms in the first trimester (β = 0.23, SE = 0.09, p = 0.02), second trimester (β = 0.09, SE = 0.03, p = 0.003), and third trimester (β = 0.04, SE = 0.02, p = 0.05). In the postnatal analyses, we included gestational age at birth as a covariate. We observed a negative association between gestational age at birth and trait anxiety (β = −0.52, SE = 0.24, p = 0.03). Discussion The results indicate that ACE alone was not directly associated with depressive symptoms, trait anxiety, or state anxiety. However, perceived stress moderated these associations for depressive symptoms and trait anxiety but not state anxiety. We examined whether these effects would emerge consistently across the perinatal period. We found that the ACE and perceived stress interaction for depression was evident across all three trimesters of pregnancy but not postnatally, whereas the interaction effect for trait anxiety was specific to the third trimester. These findings suggest the impact of ACE on maternal psychological outcomes is temporally dynamic and context dependent, emerging primarily during pregnancy, a period of heightened physiological and psychological adjustments. Drawing on the stress sensitivity model, which posits that early stress exposure heightens sensitivity to subsequent proximal stressors [22], the present findings suggest that early adversity may confer latent vulnerability that is exacerbated by current stress appraisals during pregnancy. Prior research [49] provides evidence supporting the stress sensitization model, demonstrating that individuals with a history of childhood maltreatment exhibited a stronger association between adult stressors and depression. This finding extends prior stress sensitization research by underscoring the lasting impact of early-life adversity on stress sensitivity and mental health outcomes in the prenatal period. The interaction between ACE and perceived stress for depressive symptoms demonstrated that women with higher ACE reported greater depressive symptoms at higher levels of perceived stress in the prenatal period but not in the postnatal period. From a biological embedding perspective, early adversity may be encoded in the neural, endocrine, and immune pathways that regulate stress and emotion, resulting in long-term alterations in HPA-axis regulation and inflammatory function [24, 50, 51]. The altered physiological changes during pregnancy are characterized by a heightened production of placental corticotropin-releasing hormone (CRH) and cortisol, which may reactivate these biologically embedded adaptations, resulting in an increase in emotional and physiological reactivity to perceived stress during this period [52, 53]. During pregnancy, stress reactivity is typically downregulated by an adaptation mechanism to protect the mother and fetus from stress exposure [54]. However, psychosocial stressors can alter this downregulation, increasing inflammatory response and CRH production. Consistent with this, early life adversity has been associated with a greater cortisol awakening response (CAR) during pregnancy, suggesting that early life experiences alter maternal stress responses in a way that increases their vulnerability to perceived stress [55]. Similarly, pregnant women who reported ACE showed lower baseline cortisol and disrupted CAR patterns [56]. Such endocrine and inflammatory dysregulation may contribute to affective instability in women with higher perceived stress who report ACE, consistent with evidence that links childhood trauma to heightened inflammation in adulthood [57]. Additionally, inflammatory markers such as CRP, TNF-α, and IL-6 have also been associated with depressive symptoms during pregnancy and postpartum [58]. Notably, individuals with a history of childhood maltreatment and depression may exhibit exaggerated negative feedback within the HPA axis, suggesting a distinct biological profile compared to those with depression but no history of early adversity [59]. Such dysregulation, whether characterized by hyper- or hypo-responsiveness, may increase physiological and emotional reactivity to stress, thereby increasing vulnerability to internalizing symptoms associated with depression and anxiety [59, 60]. The present study’s result suggests that pregnant women with a history of ACE may be particularly sensitive to current stressors, and elevated perceived stress may amplify anxiety and depressive symptoms through maladaptive stress appraisals and biological stress responses. Thus, perceived stress may function as a key mechanism through which the effects of early adversity contribute to poorer emotional well-being during the prenatal period. We examined the two components of the STAI to distinguish between the acute presence of anxiety symptoms (state anxiety) and individuals’ propensity to thoughts and behavioral patterns associated with anxiety symptoms (trait anxiety) [33, 61] particularly in the context of ACE. Trait anxiety is directly related to negative affectivity and heightened susceptibility to anxiety and depressive disorders [35, 62]. Moreover, ACE has been shown to manifest in emotional dispositions characterized as trait anxiety [30–32]. Previous literature has also demonstrated an association between traumatic events and trait anxiety in individuals with higher perceived stress [61]. This work enhances the literature by confirming these associations in pregnant women in the prenatal period. Contrary to previous studies [62–67], we did not observe a direct association between ACE and state or trait anxiety symptoms. Instead, our findings suggest that perceived stress plays a key role in shaping the relationship between ACE and trait anxiety in the third trimester. The emergence of this interaction effect in the third trimester may be attributed to the physiological and psychological demands of late pregnancy, such as an increase in CRH after mid-pregnancy, which further contributes to the release of cortisol [53, 54, 68]. For women with a history of ACE, who are reported to have altered baseline cortisol patterns and blunted HPA-axis responsivity [56, 69]. This pattern of response may interact with trait vulnerabilities such as worry, hypervigilance, and rumination. This also aligns with research indicating that early-life adversity may lead to dysregulation of the central stress response system, particularly the HPA-axis [24, 59, 70]. The third trimester is also marked by pregnancy-specific stress, such as anticipatory concerns about childbirth, fetal health, and body changes, which may be further exacerbated by underlying vulnerabilities in women [71, 72]. Furthermore, the reported interaction effect of ACE and perceived stress on trait anxiety in this study suggests that the distal effect of ACE on the propensity to negative affectivity and heightened stress reactivity observed later in life, particularly in the third trimester, depends on the cognitive appraisal of current stressors. Taken together, these findings highlight that the combined effect of ACE and perceived stress is most apparent during pregnancy. In contrast, no significant interaction effect was observed in the postnatal period. The absence of this effect may be due to the sharp decline in circulating CRH and cortisol after delivery, which initiates readjustment of the maternal HPA-axis and reduces the physiological demands of stress during pregnancy [53]. The absence of an interaction effect in the postnatal period supports the idea that pregnancy-specific biological processes may explain why the influence of ACE and perceived stress was evident only during the prenatal period. The transition in this period may also warrant the examination of other contextual stressors relevant to the psychosocial changes experienced by women after childbirth, such as sleep disruption and caregiving demands. While the current study did not directly examine these physiological mechanisms, the temporal pattern of our findings is consistent with prior evidence linking prenatal stress sensitivity to endocrine changes across gestation. Beyond its moderating effects, perceived stress demonstrated a reliable direct association with mental health symptoms across the perinatal period, with the exception of the first trimester of pregnancy, where findings were limited by sample size. In line with existing literature [37, 73–76], the present study demonstrated that higher levels of perceived stress were consistently associated with state anxiety, trait anxiety, and depressive symptoms. These findings highlight the important role of proximal factors like perceived stress in increasing the risk of PMADs. From a cognitive vulnerability perspective, the observed association between perceived stress and depressive symptoms suggests that individuals who perceive stress as overwhelming or uncontrollable are more likely to engage in maladaptive thinking patterns, such as rumination, which has been shown to play a mediating role between perceived stress and prenatal depression [76]. Contrary to existing literature [77, 78] our examinations of timepoints across the perinatal period further enhanced our ability to detect temporal changes in stress, mood, and anxiety symptoms, a critical advantage in perinatal research where emotional states fluctuate significantly [79]. Previous studies often examine perceived stress, anxiety, or depressive symptoms as individual indicators of prenatal distress, in particular relative to offspring developmental outcomes [5, 6, 80, 81]. Alternatively, many studies focus on the direct associations between ACE and depressive and anxiety symptoms with adverse birth outcomes or offspring development [82–84]. However, the relationship between ACE and symptoms of stress, anxiety, or depression is complex and fluctuates over time. In this work, we demonstrate that proximal factors, such as those reflected by ACE assessments, may account for individual differences in stress experiences, which in turn influence symptoms of depression and anxiety during specific life stages. It is important to note that data collection occurred during the COVID-19 pandemic, a time characterized by heightened stress and pervasive uncertainty. This may have increased participants’ perceived stress levels and potentially interacted with the impact of ACE on stress perception during the perinatal period. Strengths and limitations The strengths of the study include its examination of stress, anxiety, and depressive symptoms across different time points in the perinatal period, which provides new insight into the relationship between ACE exposure and perceived stress on anxiety and depressive symptoms over a dynamic period of time. Despite the strength of this study, there are several limitations to consider. Firstly, the disproportionately high number of low ACE in the sample may have impacted the results because there was an underrepresentation of moderate to high ACE relative to low ACE in this sample. Another limitation of the current study was that ACE is a measure using retrospective self-report, which is susceptible to recall biases and underreporting as a result of participants forgetting, reinterpreting these experiences based on current mood, or choosing not to report certain experiences. Second, the sample size in the first trimester limited the statistical power to detect significant relationships between ACE, stress, and maternal mental health symptoms in this window. In addition, the study design allowed enrollment of pregnant women across a wide gestational window, which resulted in variability regarding the number of assessments per individual. While we addressed these through the analytic approach, these limitations in study design should be considered when interpreting the results. Lastly, although the PSS is a widely used and psychometrically sound measure of perceived stress, it reflects a general appraisal of stress rather than distinguishing between specific sources (e.g., pregnancy-related, social, or adversity-related stress). While this does not undermine the validity of the associations observed, it limits our ability to determine which domains of stress are most modulatory in the effect of ACE. The current study did not examine how women perceived pregnancy-related stressors; this could have also provided more insight into possible variations in how different types of stressors are perceived relative to ACE. Future studies would benefit from incorporating distinct stress assessments to clarify these distinctions. Conclusion This work highlights the enduring influence of early life adversity on psychological well-being during the prenatal period, a uniquely sensitive window for maternal mental health. By demonstrating that perceived stress moderates the association between adverse childhood experiences and both trait anxiety and depressive symptoms, this study provides support for the stress sensitization framework and underscores the potential role of HPA-axis dysregulation as a biological mechanism underlying these associations. While the study did not include biological measures, the findings align with theoretical models, suggesting that early adversity can lead to long-term alterations in stress regulation systems, conferring heightened vulnerability during periods of increased stress. Additionally, our study underscores the importance of recognizing ACE as a risk factor to better identify individuals who may not present commonly identified social risk factors for developing psychopathological disorders, especially in prenatal care. This ensures that healthcare professionals do not overlook individuals who present symptoms but do not meet diagnostic criteria. Beyond risk recognition, our findings also highlight the need for childhood trauma-informed approaches and prenatal interventions for stress management during pregnancy, when vulnerability to stress is heightened. Moreover, the current study further establishes that the time of stress exposure is pivotal in its effect on the individuals, thus highlighting the need for a nuanced assessment of childhood trauma, such as age and duration of adverse experiences. Ultimately, it is recommended that future studies explore coping mechanisms in addition to stress appraisal and its potential impact on depressive and anxiety symptoms. Lastly, future research should employ better characterization of maternal stress by including biological and physiological markers of stress and neuropsychological assessment to provide an in-depth and objective assessment of the association between maternal ACE, stress appraisal, and perinatal depressive and anxiety symptoms. Supplementary Information Supplementary Material 1. Acknowledgements I sincerely thank my co-authors and mentors for their guidance and contributions. I am grateful to the participants for their time and willingness to contribute to this study. Abbreviations Adverse Childhood Experience Gestational Age State-Trait Anxiety Inventory Perceived Stress Scale Center for Epidemiological Studies-Depression Authors’ contributions F. Ilori: project conceptualization, methodology, formal analysis, data visualization, original draft writing, and manuscript editing; N. Niforatos-Andescavage: conceptualization, validation of data analysis, and supervision; K. Wisner: conceptualization, supervision; J. Ngwa: supervision and validation of statistical analysis; R. Govindan: data analysis, supervision, validation; C. Limperopoulos: funding acquisition, resources, supervision, validation, editing, and manuscript review; all authors reviewed, edited, and endorsed the final version of the manuscript. Funding This study was funded by the National Institutes of Health T32 HD098066 grant. Data availability Data can be requested in writing to the principal investigator. Declarations Ethics approval and consent to participate This study was approved by the Children’s National Institutional Review Board (Protocol 00014257), and all methods were carried out in accordance with institutional guidelines and regulations. Informed consent was obtained in all cases. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement Data can be requested in writing to the principal investigator.